Search Within

Urvi A Shah

Formats
  1. Meeting Abstract (136)
  2. Journal Article (38)
  3. Research Letter (12)
  4. Review (10)
  5. Correspondence (4)
  6. Editorial (2)
  7. Book Section (1)
Groups
  1. CTCR Scholars (203)
  2. Department of Medicine (203)
  3. Hematologic Malignancies, Division of (203)
  4. Center for Hematologic Malignancies (156)
  5. Myeloma (155)
  6. Hematologic Malignancies Research (150)

More Groups

People
  1. Alexander Lesokhin (146)
  2. Sham Mailankody (141)
  3. Malin Hultcrantz (135)
  4. Neha Korde (133)
  5. Hani Hassoun (132)
  6. Carlyn Rose Tan (122)

More People

Years
  1. 2025 (10)
  2. 2024 (49)
  3. 2023 (44)
  4. 2022 (44)
  5. 2021 (16)
  6. 2020 (20)

More Years

Publications
  1. Blood (76)
  2. Clinical Lymphoma, Myeloma and Leukemia (42)
  3. Journal of Clinical Oncology (15)
  4. Blood Cancer Journal (9)
  5. Blood Advances (8)
  6. Biology of Blood and Marrow Transplantation (4)

More Publications

Publishers
  1. American Society of Hematology (84)
  2. Elsevier Inc. (52)
  3. American Society of Clinical Oncology (15)
  4. Nature Publishing Group (14)
  5. American Association for Cancer Research (6)
  6. American Medical Association (4)

More Publishers

Results (203)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR T and CAR NK cells in multiple myeloma: Expanding the targets
    Review

    Shah, U. A.; Mailankody, S.
    Best Practice and Research: Clinical Haematology (2020)

    Fulltext@MSK | Save
  • Phase I study of selinexor, ixazomib, and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma
    Research Letter

    Salcedo, M.; Lendvai, N.; Mastey, D.; Schlossman, J.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States
    Journal Article

    Shah, U. A.; Shah, N.; Qiao, B.; Acuna-Villaorduna, A.; Pradhan, K.; Adrianzen Herrera, D.; Sica, R. A.; Shastri, A.; Mantzaris, I.; Derman, O.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Conventional chemotherapy treatment induces unique patterns of clonal evolution in a North American adult T cell leukemia/lymphoma cohort
    Meeting Abstract

    Sica, R. A.; Shah, N.; Acuna-Villaorduna, A.; Vishnuvardan, N.; Shah, U. A.; Herrera, D. A.; De Castro, A.; Mustafa, J.; Lombardo, A.; Khatun, F.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • VTE rates and safety analysis of newly diagnosed multiple myeloma patients receiving carfilzomib-lenalidomide-dexamethasone (KRD) with or without rivaroxaban prophylaxis
    Meeting Abstract

    Piedra, K. M.; Hassoun, H.; Buie, L. W.; Devlin, S. M.; Flynn, J.; Hultcrantz, M.; Lesokhin, A. M.; Lu, S. X.; Mailankody, S.; Shah, U. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • An observational, retrospective analysis of retreatment with carfilzomib in the management of patients with multiple myeloma
    Meeting Abstract

    Peterson, T. J.; Korde, N.; Hassoun, H.; Mailankody, S.; Lesokhin, A. M.; Hultcrantz, M.; Shah, U. A.; Smith, E. L.; Lu, S. X.; Landau, H. J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Effect of active hepatitis C infection in relapse-free survival among patients with HIV-related diffuse large B-cell lymphoma
    Meeting Abstract

    Gonzalez-Lugo, J. D.; Acuna-Villaorduna, A.; Shah, U. A.; Friedman, E. W.
    Blood (2019)

    Fulltext@MSK | Save
  • FDA analysis: Impact of body mass index (BMI) on outcomes in relapsed-refractory multiple myeloma
    Meeting Abstract

    Ershler, R.; Kanapuru, B.; Gong, Y.; Shah, U. A.; Mailankody, S.; Landgren, O.; Theoret, M.; Gormley, N. J.; Farrell, A. T.; Pazdur, R.
    Blood (2019)

    Fulltext@MSK | Save
  • MALDI-TOF mass spectrometry in serum for the follow-up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy
    Meeting Abstract

    Eveillard, M.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Smith, E. L.; Hassoun, H.; Shah, U. A.; Lu, S. X.; Korde, N.; Landgren, O.; more...
    Blood (2019)

    Fulltext@MSK | Save